Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


UC research into potential curing cardiovascular disease

UC student research into potential curing or slowing down of cardiovascular disease

November 6, 2012

A University of Canterbury student is researching key cell biology processes that may be useful in curing or slowing down the development of many diseases such as strokes and heart attacks.

Nelson’s Ben Walters is at the end of his fourth year of UC study working toward a Master of Science in Biochemistry. His area of research is on cardiovascular disease which is a leading cause of mortality in most developed countries, largely due to the ageing population and sedentary lifestyles.

In New Zealand heart attacks and strokes result are responsible for 40 percent of annual deaths, affecting around 10,000 people. Cardiovascular disease involves the build-up of fatty materials such as cholesterol in the cells within the arterial walls in a process known as atherosclerosis.

Fat deposition within the cells begins in teenage years and after enough time, blood circulation can be impaired through artery stiffening and plaque formation. These plaques can eventually rupture and form blood clots that deprive tissues of oxygen and other nutrients.

Depending on the location of clot formation, the resulting tissue damage can be in the form of a heart attack or stroke.

``My project is looking at how cells involved in cardiovascular disease regulate production of an antioxidant called 7,8-dihydroneopterin. Antioxidants are protective molecules that protect cells against oxidative stress, a process involved in cardiovascular as well as many other diseases, ‘’ Walters said today.

``An increased understanding of how cells produce such molecules many one day lead to therapeutic drugs to modulate antioxidant production. Such interventional strategies may be useful in curing or slowing down the development of many diseases.

``Biochemistry and medical research are extraordinarily fields to be involved in. Everything feels incredibly applicable, as the very processes we learn about are occurring inside ourselves and all other life on the planet.

``It is also very rewarding to know that the relatively small contribution that I am making to the vast scientific literature, may one day lead to the development of medicines which could save and improve the quality of millions of lives around the world.

``The University of Canterbury has been a great place to study, where world leading facilities/research laboratories and excellent teaching staff means anyone with the inclination can be inspired and excel in their field of interest.

``Who would want to go all the way to Dunedin when you can be at the forefront of medical research right here in Canterbury? My project follows on from four years of directed learning and will take me between 12 and 18 months to finish.’’

Walters is carrying out his research under the supervision of Associate Profession Steven Gieseg whose group has shown how key antioxidants regulate white blood cells involved in heart disease.
ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Genetics: New Heat Tolerant Cow Developed

Hamilton, New Zealand-based Dairy Solutionz Ltd has led an expert genetics team to develop a new dairy cow breed conditioned to thrive in lower elevation tropical climates and achieve high milk production under heat stress. More>>

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Auckland Outage: Power Mostly Restored Overnight

Vector wishes to advise that all but 324 customers have been restored overnight. These customers are spread throughout the network in small pockets. The main St Johns feeder was restored around midnight allowing most of the customers in all affected areas to have power this morning. More>>

ALSO:

Half Empty: Dairy Prices Drop To Lowest Since August 2009

Dairy product prices fell to the lowest level in more than five years in the latest GlobalDairyTrade auction, led by declines in butter milk powder and whole milk powder. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
More RSS  RSS
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news